| 10835533 |
1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor |
Shelley Allen, Brian Baer, Zackary Crane, Weidong Liu, Daniel J. Watson |
2020-11-17 |
| 10774085 |
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds |
Julia Haas, Yutong Jiang, Gan Zhang |
2020-09-15 |
| 10766881 |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases |
James F. Blake, Adam Cook, Indrani W. Gunawardana, Kevin W. Hunt, Andrew T. Metcalf +3 more |
2020-09-08 |
| 10758542 |
Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors |
Shelley Allen, Kevin Ronald Condroski, Julia Haas, Lily Huang, Yutong Jiang +2 more |
2020-09-01 |
| 10724102 |
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same |
Nisha Nanda, Joshua H. Bilenker, James F. Blake, Gabrielle R. Kolakowski, Barbara J. Brandhuber |
2020-07-28 |
| 10688100 |
Macrocylic compounds as ROS1 kinase inhibitors |
James F. Blake, Julia Haas, Gabrielle R. Kolakowski |
2020-06-23 |
| 10655186 |
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same |
Nisha Nanda, Joshua H. Bilenker, James F. Blake, Gabrielle R. Kolakowski, Barbara J. Brandhuber |
2020-05-19 |
| 10647730 |
Macrocyclic compounds as TRK kinase inhibitors |
Kevin Ronald Condroski, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski, Jeongbeob Seo +2 more |
2020-05-12 |
| 10590139 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds |
Julia Haas, Yutong Jiang, Gan Zhang |
2020-03-17 |
| 10555944 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook, Julia Haas +9 more |
2020-02-11 |